Concepedia

Author

Antonio Fontanellas

Universidad de NavarraORCID

Also Known As

A Fontanellas, A. FONTANELLAS, A. Fontanellas, ANTONIO FONTANELLAS, Antonio Fontanellas, H. de Verneuil, Yuichi Kitano

118

Publications

2.3K

Citations

25

H-Index

88

Concepts

All Affiliations

Universidad de NavarraHospital Universitario 12 De OctubreCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y DigestivasResearch Institute Hospital 12 de OctubreNavarre Institute of Health Research
AF

About

Antonio Fontanellas is an author at Universidad de Navarra specializing in medicine, porphyrias, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

20

600

2

Health Sciences

6

6

175

3

Engineering

3

3

49

4

Public Health

1

1

30

5

Allergy

1

1

20

Antonio Fontanellas

×

44

Publications

1.7K

Citations

22

H-Index

YearCitations

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Lei Jiang, Pedro Berraondo, Daniel Jericó,

Nature Medicine

2018

176

Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage

María J. Perugorria, Aitor Esparza-Baquer, Fiona Oakley,

Gut

2018

145

Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria

Delia D’Avola, Esperanza López‐Franco, Bruno Sangro,

Journal of Hepatology

2016

139

A Novel Immunodeficient Mouse Model-RAG2 gamma Cytokine Receptor Chain Double Mutants-Requiring Exogenous Cytokine Administration for Human Hematopoietic Stem Cell Engraftment Common

Frédéric Mazurier, Antonio Fontanellas, Stéphanie Salesse,

Journal of Interferon & Cytokine Research

1999

130

Effect of Adeno-Associated Virus Serotype and Genomic Structure on Liver Transduction and Biodistribution in Mice of Both Genders

Astrid Pañeda, Lucía Vanrell, Itsaso Mauleón,

Human Gene Therapy

2009

107

Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates

Carmen Unzu, Sandra Hervás‐Stubbs, Ana Sampedro,

Journal of Translational Medicine

2012

68

Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection

María‐Josefa Morán‐Jiménez, Antonio Fontanellas, E. Brudieux,

Hepatology

1998

67

Sustained Enzymatic Correction by rAAV-Mediated Liver Gene Therapy Protects Against Induced Motor Neuropathy in Acute Porphyria Mice

Carmen Unzu, Ana Sampedro, Itsaso Mauleón,

Molecular Therapy

2010

61

Safety and Liver Transduction Efficacy of rAAV5- <i>cohPBGD</i> in Nonhuman Primates: A Potential Therapy for Acute Intermittent Porphyria

Astrid Pañeda, Esperanza López‐Franco, Christine Kaeppel,

Human Gene Therapy

2013

60

Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without Preselection

Emmanuel Richard, Manuel Méndez, Frédéric Mazurier,

Molecular Therapy

2001

60

Page 1